Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Interest Expenses (2023 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Interest Expenses for 3 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • Quarterly Interest Expenses fell 15.75% to $3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, down 16.27% year-over-year, with the annual reading at $14.6 million for FY2025, 16.27% down from the prior year.
  • Interest Expenses hit $3.5 million in Q4 2025 for Harmony Biosciences Holdings, down from $3.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $7.0 million in Q3 2023 to a low of $3.5 million in Q4 2025.
  • Historically, Interest Expenses has averaged $4.7 million across 3 years, with a median of $4.4 million in 2024.
  • Biggest YoY gain for Interest Expenses was 12.24% in 2024; the steepest drop was 37.99% in 2024.
  • Year by year, Interest Expenses stood at $4.8 million in 2023, then fell by 12.24% to $4.2 million in 2024, then decreased by 15.75% to $3.5 million in 2025.
  • Business Quant data shows Interest Expenses for HRMY at $3.5 million in Q4 2025, $3.6 million in Q3 2025, and $3.6 million in Q2 2025.